CPHI Middle East returns to Riyadh, from December 14–16, 2026, at the Riyadh Exhibition and Convention Centre, Malham, with even greater momentum, building on the remarkable success of its 2024 edition, which drew more than 30,000 visitors from over 100 countries.

The CPHI Middle East upcoming event is poised to become a defining moment for the region’s rapidly expanding pharmaceutical landscape, offering an unparalleled platform for global industry engagement. Moreover, the 2026 edition will deepen its focus on high‑value networking, enabling attendees to connect directly with manufacturers, suppliers, regulators, and innovators shaping the future of healthcare in the Middle East and beyond. With the region continuing to invest heavily in pharmaceutical manufacturing, localisation strategies, and advanced healthcare infrastructure, CPHI Middle East offers a timely gateway for companies seeking to enter or expand in the market. Visitors can expect comprehensive insights into evolving regulatory frameworks, including updates that influence market access, quality standards, and compliance across the supply chain. Thought‑leading sessions will spotlight breakthroughs in drug development, digital health, biotechnology, and advanced manufacturing technologies, reflecting the sector’s accelerating pace of innovation. Furthermore, the exhibition floor will showcase a full spectrum of products and services—from APIs and finished formulations to packaging, machinery, laboratory equipment, and contract services—offering a complete view of the global pharmaceutical ecosystem. This breadth ensures that stakeholders from every segment of the value chain can find relevant partners and opportunities. As the Middle East strengthens its position as a strategic pharmaceutical hub, the 2026 edition of CPHI Middle East promises to deliver expanded opportunities, deeper collaboration, and a clearer view of the region’s role in shaping the future of global healthcare. Read more: Saudi FM & Clean, 2026